Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials.

Authors :: Martino EA
Derudas D
Rossi E
Terlizzi S
Reddiconto G
Stefanoni P
Micozzi J
Mangiacavalli S
Zamagni E
Offidani M
Furlan A
Buda G
Lotti F
Liberatore C
Lazzaro A
Pepa RD
Bertuglia G
Barbieri E
Conticello C
De Magistris C
De Paoli L
Bongarzoni V
Cafro AM
Mele A
Benvenuti P
Cerchione C
Botta C
Antonioli E
Sgherza N
Aquino S
Mele G
Barilà G
Palmieri S
Annibali O
Bianco R
Febbo MA
Casaluci GM
Rago A
Fontana R
Farina F
Vigna E
Bruzzese A
Mancuso K
Nappi D
Morè S
Rivolti E
Califano C
Amendola A
Roccotelli D
Lombardo A
Citro A
Uccello G
Zambello R
Maggi A
Neri S
Monachesi M
Gozzetti A
Montefusco V
Brunori M
Cotzia E
Pietrantuono G
Quinto AM
Amico V
Di Renzo N
Coscia M
Galli M
De Stefano V
Petrucci MT
Neri A
Di Raimondo F
Morabito F
Musto P
Gentile M
Source :: Haematologica [Haematologica] 2024 Nov 28. Date of Electronic Publication: 2024 Nov 28.
Publication Year :: 2024
Publisher :: Ahead of Print
Abstract: Not available.

Full Text Access

Tools